Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial-Reference-Cited by-同舟云学术

Panobinostat activity in both bexarotene-exposed and -naïve patients with refractory cutaneous T-cell lymphoma: Results of a phase II trial

Published:2013-01 Issue:2 Volume:49 Page:386-394
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Duvic Madeleine,Dummer Reinhard,Becker Jürgen C.,Poulalhon Nicolas,Ortiz Romero Pablo,Grazia Bernengo Maria,Lebbé Celeste,Assaf Chalid,Squier Margaret,Williams Denise,Marshood Miriam,Tai Feng,Prince H. Miles

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference33 articles.

1. WHO–EORTC classification for cutaneous lymphomas;Willemze;Blood,2005

2. Primary cutaneous lymphoma: two-decade comparison in a population of 263 cases from a Swiss tertiary referral centre;Jenni;Br J Dermatol,2011

3. High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascade;Kiessling;Blood,2011

4. Dummer R, Dreyling M; ESMO Guidelines Working Group. Primary cutaneous lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008;19 (Suppl. 2):ii72–6.

5. Treatment of cutaneous T-cell lymphoma with retinoids;Zhang;Dermatol Ther,2006

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic transplantation and cellular therapies in cutaneous T-cell lymphoma;Expert Review of Anticancer Therapy;2024-01-26

2. Journal Club: Mycosis fungoides and Sézary syndrome: an update on a classic disease;European Journal of Dermatology;2023-12

3. What’s New in Cutaneous T-Cell Lymphoma-Associated Pruritus;American Journal of Clinical Dermatology;2023-11-16

4. Inhibiteurs d’histones désacétylase et lymphomes T cutanés épidermotropes (mycosis fongoïde et syndrome de Sézary);Annales de Dermatologie et de Vénéréologie - FMC;2023-07

5. Clinical advances in epigenetic therapies for lymphoma;Clinical Epigenetics;2023-03-04